Division of Hematology/Oncology, Department of Medicine.
Molecular, Cellular and Integrative Physiology.
JCI Insight. 2018 Jun 7;3(11). doi: 10.1172/jci.insight.98197.
Oncogenic Kras expression specifically in hematopoietic stem cells (HSCs) induces a rapidly fatal myeloproliferative neoplasm in mice, suggesting that Kras signaling plays a dominant role in normal hematopoiesis. However, such a conclusion is based on expression of an oncogenic version of Kras. Hence, we sought to determine the effect of simply increasing the amount of endogenous wild-type Kras on HSC fate. To this end, we utilized a codon-optimized version of the murine Kras gene (Krasex3op) that we developed, in which silent mutations in exon 3 render the encoded mRNA more efficiently translated, leading to increased protein expression without disruption to the normal gene architecture. We found that Kras protein levels were significantly increased in bone marrow (BM) HSCs in Krasex3op/ex3op mice, demonstrating that the translation of Kras in HSCs is normally constrained by rare codons. Krasex3op/ex3op mice displayed expansion of BM HSCs, progenitor cells, and B lymphocytes, but no evidence of myeloproliferative disease or leukemia in mice followed for 12 months. BM HSCs from Krasex3op/ex3op mice demonstrated increased multilineage repopulating capacity in primary competitive transplantation assays, but secondary competitive transplants revealed exhaustion of long-term HSCs. Following total body irradiation, Krasex3op/ex3op mice displayed accelerated hematologic recovery and increased survival. Mechanistically, HSCs from Krasex3op/ex3op mice demonstrated increased proliferation at baseline, with a corresponding increase in Erk1/2 phosphorylation and cyclin-dependent kinase 4 and 6 (Cdk4/6) activation. Furthermore, both the enhanced colony-forming capacity and in vivo repopulating capacity of HSCs from Krasex3op/ex3op mice were dependent on Cdk4/6 activation. Finally, BM transplantation studies revealed that augmented Kras expression produced expansion of HSCs, progenitor cells, and B cells in a hematopoietic cell-autonomous manner, independent from effects on the BM microenvironment. This study provides fundamental demonstration of codon usage in a mammal having a biological consequence, which may speak to the importance of codon usage in mammalian biology.
致癌 Kras 表达特异性在造血干细胞(HSCs)中诱导小鼠迅速致命的骨髓增生性肿瘤,表明 Kras 信号在正常造血中起主导作用。然而,这样的结论是基于表达致癌形式的 Kras。因此,我们试图确定简单增加内源性野生型 Kras 的量对 HSC 命运的影响。为此,我们利用了我们开发的一种密码子优化的鼠 Kras 基因(Krasex3op),其中外显子 3 中的沉默突变使编码的 mRNA 更有效地翻译,导致蛋白表达增加,而不会破坏正常的基因结构。我们发现,Kras 蛋白水平在 Krasex3op/ex3op 小鼠的骨髓(BM)HSCs 中显著增加,表明 HSCs 中的 Kras 翻译通常受到稀有密码子的限制。Krasex3op/ex3op 小鼠显示 BM HSCs、祖细胞和 B 淋巴细胞扩张,但在 12 个月的随访中没有发现骨髓增生性疾病或白血病的证据。Krasex3op/ex3op 小鼠 BM HSCs 在原发性竞争移植试验中显示出增加的多谱系重植能力,但二次竞争移植显示出长期 HSCs 的衰竭。在全身照射后,Krasex3op/ex3op 小鼠显示出血液学恢复加速和存活率增加。从机制上讲,Krasex3op/ex3op 小鼠的 HSCs 在基线时表现出增加的增殖,相应地增加了 Erk1/2 磷酸化和细胞周期蛋白依赖性激酶 4 和 6(Cdk4/6)的激活。此外,Krasex3op/ex3op 小鼠的 HSCs 增强的集落形成能力和体内重植能力都依赖于 Cdk4/6 的激活。最后,BM 移植研究表明,增强的 Kras 表达以造血细胞自主的方式导致 HSCs、祖细胞和 B 细胞的扩张,与对 BM 微环境的影响无关。这项研究提供了哺乳动物密码子使用具有生物学后果的基本证明,这可能表明密码子使用在哺乳动物生物学中的重要性。